Holen Sie sich die Stockscreener-App
1.74
0.57%
-0.01
Handel nachbörslich:
1.76
0.02
+1.15%
Finanzdaten der Engene Therapeutics Inc-Aktie (ENGN)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2024-07-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
21.01%
31.18
|
39.48 | 29.95 | 27.12 | 16.76 |
| Operating Income/Loss |
21.01%
-31.18
|
-39.48 | -29.95 | -27.12 | -16.76 |
| Nonoperating Income/Loss |
29.80%
1.433
|
1.104 | 1.195 | 1.549 | 2.582 |
| Income/Loss From Continuing Operations Before Tax |
22.47%
-29.75
|
-38.38 | -28.75 | -25.57 | -14.18 |
| Income Tax Expense/Benefit |
100.00%
-
|
-0.497 | 0.239 | 0.24 | -0.029 |
| Income/Loss From Continuing Operations After Tax |
21.46%
-29.75
|
-37.88 | -28.99 | -25.82 | -14.15 |
|
Net Income/Loss
|
21.46%
-29.75
|
-37.88 | -28.99 | -25.82 | -14.15 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
76,456%
67.26
|
0.0879 | 51.10 | 51.02 | 44.17 |
| Diluted Average Shares |
76,456%
67.26
|
0.0879 | 51.10 | 51.02 | 44.17 |
| Basic Earnings Per Share |
39.73%
0.44
|
0.73 | 0.57 | 0.51 | 0.32 |
| Diluted Earnings Per Share |
39.73%
0.44
|
0.73 | 0.57 | 0.51 | 0.32 |
| Common Stock Dividends |
-
|
- | - | - | - |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.60%
0.94%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):